.png)
Is it poor sleep or is it insomnia disorder?
Watch an episode of our latest series, Big Health Talks, where two clinicians discuss everything you need to know about insomnia.
Welcome to our first segment of Big Health Talks, where we speak with thought leaders in the industry about trends, problems, and solutions related to mental health, specifically insomnia and anxiety.
In our first episode, Jenna Carl, PhD, Chief Medical Officer at Big Health, and Andrew Krystal, MD, MS, Professor and Vice Chair for Research in the Department of Psychiatry at UCSF, discuss everything you need to know about insomnia: how to define it, treatment plans, and the role digital therapeutics play in expanding access to care.
What is insomnia disorder?
What is the promise of digital therapeutics for insomnia?
Where do digital therapeutics fit in with a treatment plan and with providers?
Watch and listen to the full conversation between Dr. Carl and Dr. Krystal below for more information on insomnia and the benefits of digital therapeutics.
Dr. Krystal is a paid consultant for Big Health.
DOC-2750 Effective 04/2023
Subscribe to blog
Here’s our latest
.jpeg)
During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.
1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.
DOC-3046 Effective 11/2023